Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa

Australasian Psychiatry

Volumn 13, Issue 1, 2005, Pages 72-75

  Mondraty, Naresh ^a   Laird Birmingham, C ^b   Touyz, Stephen ^c   Sundakov, Viktoria ^d   Chapman, Lucy ^d   Beumont, Pierre ^d  

^a Peter Beumont Eating Disorder Serv   (Australia)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Anorexia nervosa; Chlorpromazine; Eating disorders; Olanzapine; Randomized controlled trial

Indexed keywords

CHLORPROMAZINE; OLANZAPINE;

ADULT; ANOREXIA NERVOSA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; LOW DRUG DOSE; MAXIMUM PERMISSIBLE DOSE; ORTHOSTATIC HYPOTENSION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

ADULT; ANOREXIA NERVOSA; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHLORPROMAZINE; COGNITION DISORDERS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE;

EID: 17144417205     PISSN: 10398562     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1665.2004.02154.x     Document Type: Article

References (9)

1. Sunday S, Halmi K, Einhorn A. The Yale-Brown-Cornell Eating Disorder Scale: a new scale to assess eating disorder symptomatology. International Journal of Eating Disorders 1995; 18: 237-245.
2. Herzog DB, Nussbaum KM, Marmor AK. Comorbidity and outcome in the eating disorders. Psychiatric Clinics of North America 1996: 19: 842-859.
3. Attia E. Mayer L. Killory J. Medication response in the treatment of patients with anorexia nervosa. Journal of Psychiatric Practice 2001: 7: 157-162.
4. Ferguson C, Pigott T. Anorexia and bulimia nervosa. Neurobiology and pharmacotherapy. Behaviour Therapy 2000: 31: 237-263.
5. Powers P, Santana C. Bannon Y. Olanzapine in the treatment of anorexia nervosa: an open label trial. International Journal of Eating Disorders 2002; 32: 146-154.
6. American Psychiatric Association. Diagnostic and Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
7. Garner D. Eating Inventory-2: Professional Manual. Odessa, FL, USA: Psuchological Assessment Resources, 1991.
8. Sanavio E. Obsessions and compulsions. The Padua Inventory. Behaviour Research Therapeutics 1988; 1: 169-177.
9. Arnes D, Camm J, Johnson G. Minimizing the risks associated with significant QTc prolongation in people with schizophrenia: a consensus statement by the Cardiac Safety in Schizophrenia Group. Australian Psychiatry 2002; 10: 115-124.